Effective Sterile Powder Transfer for Parenteral Drug Products
Key Takeaways:
- Evonik implemented the AseptiSafe® Bio Valve and STERIS VHP™ 1000ED unit to enable aseptic, high-throughput powder transfer in Grade A (ISO 5) cleanroom.
- The VHP® 1000ED enabled 45-minute validated cycles, allowing near-continuous operation with minimal downtime.
- The split butterfly valve maintained a sterile, sealed connection—preventing particulate release during container changes.
- Mobile, flexible deployment supports cleanrooms with spatial constraints and varying layouts.
- The system complies with EU GMP Annex 1, improving both operational safety and production efficiency.
Personalized medicine is an evolving field — offering targeted solutions that benefit patients by minimizing side effects and increasing effectiveness. This introduces a need for specialized fill-finish equipment that can efficiently route product into final packaging in an aseptic manner.
Parenteral medications are often packaged in one of two forms: an aqueous solution or a dry powder that is dissolved in a solvent prior to administration. While both forms present unique challenges, powder products are particularly difficult to fill in an aseptic environment.
One of the key requirements for a Grade A level (ISO 5) environment is low particulates. Handling a powder product, which inherently generates particulates, requires precise control.
This case study examines how Evonik, a leading global contract development and manufacturing organization (CDMO), improved its powder transfer process for parenteral drug products without compromising efficiency or safety.
Suggested Content
Scientific Justification for Monitoring Indirect Product Contact Surfaces
The Advantages of Decontaminating with Vapor Hydrogen Peroxide
Cleanroom Cleaning Procedures: Transfers to Controlled Environments
Join our email list for the latest industry news and product updates.
By clicking Subscribe you're confirming that you agree with our Terms and Conditions.